Zota HealthCare Ltd is a pharmaceutical company with headquarters in Surat, Gujarat, India. With 23 divisions, it is one of the largest pharmaceutical companies in India. Zota HealthCare has more than 3,300 brands in the Indian market. The company's turn over in 2013 was near INR 1 billion.
ZHCL manufactures branded medicines generic medicines and patent products in India. As of October, 2013, ZHCL's main area of focus is on patented products, including RT-Fit and GM-Fit. RT-Fit is approved by PCT (Patent Corporation Treaty) and can be sold by ZHCL in 142 countries. ZHCL intends to apply for 15 more product patents in the Indian market, seven of which will be sent to PCT for approval. 
Zota HealthCare Ltd planned to issue an initial public offering (IPO) in April or May 2014, hoping to raise Rs. 4-5 billion and to invest Rs. 600-700 million in research and development. It also planned to explore business opportunities in the US and Europe market.